Viyash Scientific, through subsidiary Alivira Animal Health, has signed a binding agreement to acquire 100% stake in Italian pet care firm BioForLife Italia S.r.l. (BFL) for around Rs.188 crore.Based in Milan, BioforLife specialises in development, commercialisation and distribution of pet care products. It has established strong positions in nutritional complements, pharmaceuticals and rapid diagnostic tests. BFL is also building a business in fast growing segments like dermatology and ophthalmology. The acquisition will provide Viyash a platform for launching new products from Alivira’s pipeline in Italy, while simultaneously providing opportunities to expand the BFL range to other markets in the Alivira group located in Europe, the Middle East, Asia and LATAM, the Hyderbad-based Viyash said in a release on Monday.“BioForLife provides us with an established platform in Italy, one of Europe’s most attractive pet care markets, while strengthening our presence across the region,” Viyash Managing Director and Group CEO Haribabu Bodeputi said.The combination of BioForLife’s commercial reach and Alivira’s product development capabilities creates a compelling opportunity to accelerate growth. “We also see meaningful opportunities to introduce innovative products into India and other geographies through our global reach,” he said.EOM Published - June 08, 2026 10:03 pm IST